BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Collagenase clostridium histolyticum: Phase IIa started

Auxilium began an open-label, U.S. Phase IIa trial to evaluate 0.29-0.58 mg Xiaflex every 3 weeks for up to 3 injections plus shoulder exercises vs. exercises alone in about 50 patients. The product is marketed in the U.S. and...

Read the full 171 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >